Loading...

Home
Stock
TVTX

TVTX News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TVTX News

Travere Therapeutics to Present at Guggenheim Biotech Summit 2026

3 days agoNewsfilter

Investigation into Potential Securities Violations at Travere Therapeutics

Jan 31 2026Globenewswire

Robbins Geller Investigates Potential Securities Violations by Travere Therapeutics

Jan 28 2026PRnewswire

Palisades Investment Partners Acquires $5.26M Stake in Travere Therapeutics

Jan 25 2026Fool

Palisades Investment Partners Acquires $5.26M Stake in Travere Therapeutics

Jan 24 2026Fool

Palisades Acquires 137,768 Shares of Travere Therapeutics for $5.26 Million

Jan 24 2026NASDAQ.COM

Travere Therapeutics (TVTX) FDA Review Extended to April 13

Jan 23 2026Yahoo Finance

Oversold Stocks: Travere, Hims, and Enovis Present Buying Opportunities

Jan 21 2026Benzinga

TVTX Events

No data

No data

TVTX Monitor News

Travere Therapeutics Reports Strong FILSPARI Sales Amid FDA Review

Travere Therapeutics rises amid market strength

TVTX Earnings Analysis

No Data

No Data

People Also Watch